On the public citation graph
Design and Characterization of Libraries of Molecular Fragments for Use in NMR Screening against Protein Targets
0 signed · 157 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ange.200390202openalex-snapshot
NMR‐Techniken zum Screening und zur Identifizierung der Bindung von Liganden an Proteinrezeptoren
inferredcites →https://doi.org/10.1006/jmre.1998.1598openalex-snapshot
Multiple-Pulse Mixing Sequences That Selectively Enhance Chemical Exchange or Cross-Relaxation Peaks in High-Resolution NMR Spectra
inferredcites →https://doi.org/10.1016/0045-6535(95)00026-5openalex-snapshot
AQUAFAC 3: aqueous functional group activity coefficients; application to the estimation of aqueous solubility
inferredcites →https://doi.org/10.1016/s0169-409x(96)00423-1openalex-snapshot
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
inferredcites →https://doi.org/10.1016/s0223-5234(00)01186-7openalex-snapshot
Prediction of aqueous solubility for a diverse set of organic compounds based on atom-type electrotopological state indices
inferredcites →https://doi.org/10.1016/s1074-5521(00)00063-6openalex-snapshot
Inhibition of cyclin-dependent kinases, GSK-3β and CK1 by hymenialdisine, a marine sponge constituent
inferredcites →https://doi.org/10.1016/s1074-5521(01)00015-1openalex-snapshot
A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells
inferredcites →https://doi.org/10.1016/s1074-5521(02)00309-5openalex-snapshot
A Novel Class of Small Functional Peptides that Bind and Inhibit Human α-Thrombin Isolated by mRNA Display
inferredcites →https://doi.org/10.1016/s1359-6446(00)01616-0openalex-snapshot
Library design for NMR-based screening
inferredcites →https://doi.org/10.1016/s1359-6446(03)02796-xopenalex-snapshot
NMR-based screening technologies
inferredcites →https://doi.org/10.1016/s1359-6446(03)02831-9openalex-snapshot
A ‘Rule of Three’ for fragment-based lead discovery?
inferredcites →https://doi.org/10.1016/s1367-5931(03)00062-0openalex-snapshot
High-throughput crystallography to enhance drug discovery
inferredcites →https://doi.org/10.1021/ci034043lopenalex-snapshot
Development of a Method for Evaluating Drug-Likeness and Ease of Synthesis Using a Data Set in Which Compounds Are Assigned Scores Based on Chemists' Intuition
inferredcites →https://doi.org/10.1021/ci970056lopenalex-snapshot
Lead Discovery Using Stochastic Cluster Analysis (SCA): A New Method for Clustering Structurally Similar Compounds
inferredcites →https://doi.org/10.1021/jm010036hopenalex-snapshot
Measuring Molecular Similarity and Diversity: Total Pharmacophore Diversity
inferredcites →https://doi.org/10.1021/jm010927popenalex-snapshot
SAR and X-ray. A New Approach Combining Fragment-Based Screening and Rational Drug Design: Application to the Discovery of Nanomolar Inhibitors of Src SH2
inferredcites →https://doi.org/10.1021/jm015507eopenalex-snapshot
Simple Selection Criteria for Drug-like Chemical Matter
inferredcites →https://doi.org/10.1021/jm020017nopenalex-snapshot
Molecular Properties That Influence the Oral Bioavailability of Drug Candidates
inferredcites →https://doi.org/10.1021/jm9602928openalex-snapshot
The Properties of Known Drugs. 1. Molecular Frameworks
inferredcites →https://doi.org/10.1021/jm9903996openalex-snapshot
Properties of Known Drugs. 2. Side Chains
inferredcites →https://doi.org/10.1023/a:1008354229396openalex-snapshot
Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water*
inferredcites →https://doi.org/10.1038/nbt1092-1108openalex-snapshot
Europe's Emerging Biopharmaceutical Companies
inferredcites →https://doi.org/10.1093/protein/14.1.47openalex-snapshot
Experimental and computational mapping of the binding surface of a crystalline protein
inferredcites →https://doi.org/10.1111/j.1432-1033.1997.0518a.xopenalex-snapshot
Inhibition of Cyclin‐Dependent Kinases by Purine Analogues
inferredcites →https://doi.org/10.1126/science.274.5292.1531openalex-snapshot
Discovering High-Affinity Ligands for Proteins: SAR by NMR
inferredcites →https://doi.org/10.2174/1568026033392796openalex-snapshot
Application of NMR Screening in Drug Discovery
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/0471266949.bmc265openalex-snapshot
Fragment‐Based Lead Discovery
inferred← citeshttps://doi.org/10.1002/9780470584170.ch4openalex-snapshot
Fragment‐Based Lead Discovery
inferred← citeshttps://doi.org/10.1002/9780470721551.ch1openalex-snapshot
Introduction to Fragment‐Based Drug Discovery
inferred← citeshttps://doi.org/10.1002/9780470972137.ch6openalex-snapshot
Discovery of Inhibitors of Protein–Protein Interactions by Screening Chemical Libraries
inferred← citeshttps://doi.org/10.1002/9780470972137.ch9openalex-snapshot
In VitroScreening: Screening by Nuclear Magnetic Resonance
inferred← citeshttps://doi.org/10.1002/9781118681121.ch4openalex-snapshot
Fragment‐Based Ligand Discovery
inferred← citeshttps://doi.org/10.1002/9783527619368.ch16openalex-snapshot
Docking and Scoring for Structure‐based Drug Design
inferred← citeshttps://doi.org/10.1002/9783527619375.ch15bopenalex-snapshot
Chemical Biology of Kinases Studied by NMR Spectroscopy
inferred← citeshttps://doi.org/10.1002/9783527633326.ch17openalex-snapshot
Fragment‐Based Approaches in Virtual Screening
inferred← citeshttps://doi.org/10.1002/9783527677016.ch6openalex-snapshot
Hit and Lead Identification from Fragments
inferred← citeshttps://doi.org/10.1002/9783527683604.ch01openalex-snapshot
The Role of Fragment‐based Discovery in Lead Finding
inferred← citeshttps://doi.org/10.1002/9783527683604.ch06openalex-snapshot
The Synthesis of Biophysical Methods In Support of Robust Fragment‐Based Lead Discovery
inferred← citeshttps://doi.org/10.1002/9783527683604.ch09openalex-snapshot
Computational Methods to Support Fragment‐based Drug Discovery
inferred← citeshttps://doi.org/10.1002/ange.201506783openalex-snapshot
Organische Chemie für die fragmentbasierte Wirkstoffentwicklung (FBDD)
inferred← citeshttps://doi.org/10.1002/anie.201506783openalex-snapshot
Opportunity Knocks: Organic Chemistry for Fragment‐Based Drug Discovery (FBDD)
inferred← citeshttps://doi.org/10.1002/cem.2994openalex-snapshot
Mapping of Activity through Dichotomic Scores (MADS): A new chemoinformatic approach to detect activity‐rich structural regions
inferred← citeshttps://doi.org/10.1002/chem.201003432openalex-snapshot
Targeting Norovirus Infection—Multivalent Entry Inhibitor Design Based on NMR Experiments
inferred← citeshttps://doi.org/10.1002/chin.200507234openalex-snapshot
Design and Characterization of Libraries of Molecular Fragments for Use in NMR Screening Against Protein Targets.
inferred← citeshttps://doi.org/10.1002/cmdc.200500102openalex-snapshot
FlexNovo : Structure‐Based Searching in Large Fragment Spaces
inferred← citeshttps://doi.org/10.1002/cmdc.201100433openalex-snapshot
Complementary Screening Techniques Yielded Fragments that Inhibit the Phosphatase Activity of Soluble Epoxide Hydrolase
inferred← citeshttps://doi.org/10.1002/qsar.200520136openalex-snapshot
Compound Selection and Filtering in Library Design
inferred← citeshttps://doi.org/10.1002/wcms.1098openalex-snapshot
Fragment library design considerations
inferred← citeshttps://doi.org/10.1007/1-4020-4407-0_3openalex-snapshot
Introduction to Fragment Screening
inferred← citeshttps://doi.org/10.1007/1-4020-4407-0_5openalex-snapshot
Fragment-Based Screening by X-ray Crystallography
inferred← citeshttps://doi.org/10.1007/128_2011_179openalex-snapshot
Fragment Screening Using X-Ray Crystallography
inferred← citeshttps://doi.org/10.1007/128_2011_181openalex-snapshot
Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening
inferred← citeshttps://doi.org/10.1007/128_2011_182openalex-snapshot
Fragment-Based Approaches and Computer-Aided Drug Discovery
inferred← citeshttps://doi.org/10.1007/128_2011_183openalex-snapshot
Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors
inferred← citeshttps://doi.org/10.1007/978-1-0716-1197-5_11openalex-snapshot
Fragment Screening by NMR
inferred← citeshttps://doi.org/10.1007/978-1-4939-2486-8_13openalex-snapshot
Fragment-Based Design of Kinase Inhibitors: A Practical Guide
inferred← citeshttps://doi.org/10.1007/978-1-60761-931-4_11openalex-snapshot
Design of Screening Collections for Successful Fragment-Based Lead Discovery
inferred← citeshttps://doi.org/10.1007/s00216-008-2477-yopenalex-snapshot
Direct optical detection in fragment-based screening
inferred← citeshttps://doi.org/10.1007/s10822-009-9264-5openalex-snapshot
Design of compound libraries for fragment screening
inferred← citeshttps://doi.org/10.1007/s10822-009-9280-5openalex-snapshot
Lessons for fragment library design: analysis of output from multiple screening campaigns
inferred← citeshttps://doi.org/10.1007/s10822-009-9284-1openalex-snapshot
The multiple roles of computational chemistry in fragment-based drug design
inferred← citeshttps://doi.org/10.1007/s10822-011-9434-0openalex-snapshot
Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metrics
inferred← citeshttps://doi.org/10.1007/s10822-011-9461-xopenalex-snapshot
Design of a Fragment Library that maximally represents available chemical space
inferred← citeshttps://doi.org/10.1007/s10822-022-00469-yopenalex-snapshot
FastGrow: on-the-fly growing and its application to DYRK1A
inferred← citeshttps://doi.org/10.1007/s10858-005-0948-4openalex-snapshot
Determining the optimal size of small molecule mixtures for high throughput NMR screening
inferred← citeshttps://doi.org/10.1007/s10969-007-9036-1openalex-snapshot
Structural genomics of protein phosphatases
inferred← citeshttps://doi.org/10.1016/b0-08-045044-x/00261-3openalex-snapshot
Lead Discovery and the Concepts of Complexity and Lead-Likeness in the Evolution of Drug Candidates
inferred← citeshttps://doi.org/10.1016/b0-08-045044-x/00277-7openalex-snapshot
New Applications for Structure-Based Drug Design
inferred← citeshttps://doi.org/10.1016/b978-0-08-099420-8.00004-3openalex-snapshot
Step IIIb: The Drug-Like Chemical Diversity Pool: Diverse and Targeted Compound Collections
inferred← citeshttps://doi.org/10.1016/b978-0-12-381274-2.00001-7openalex-snapshot
Designing a Diverse High-Quality Library for Crystallography-Based FBDD Screening
inferred← citeshttps://doi.org/10.1016/b978-0-12-381274-2.00004-2openalex-snapshot
Predicting the Success of Fragment Screening by X-Ray Crystallography
inferred← citeshttps://doi.org/10.1016/b978-0-12-381274-2.00007-8openalex-snapshot
How to Avoid Rediscovering the Known
inferred← citeshttps://doi.org/10.1016/b978-0-12-381274-2.00009-1openalex-snapshot
Practical Aspects of NMR-Based Fragment Screening
inferred← citeshttps://doi.org/10.1016/b978-0-12-381274-2.00020-0openalex-snapshot
Experiences in Fragment-Based Lead Discovery
inferred← citeshttps://doi.org/10.1016/b978-0-12-397176-0.00003-0openalex-snapshot
The small molecule drug discovery process – from target selection to candidate selection
inferred← citeshttps://doi.org/10.1016/j.bmc.2015.04.005openalex-snapshot
Lead-oriented synthesis: Investigation of organolithium-mediated routes to 3-D scaffolds and 3-D shape analysis of a virtual lead-like library
inferred← citeshttps://doi.org/10.1016/j.bmc.2020.115495openalex-snapshot
Synthesis, state-of-the-art NMR-binding and molecular modeling study of new benzimidazole core derivatives as Pin1 inhibitors: Targeting breast cancer
inferred← citeshttps://doi.org/10.1016/j.bmcl.2009.11.090openalex-snapshot
Structure-guided design of α-amino acid-derived Pin1 inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmcl.2010.09.063openalex-snapshot
Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution
inferred← citeshttps://doi.org/10.1016/j.bmcl.2013.03.028openalex-snapshot
Learning from our mistakes: The ‘unknown knowns’ in fragment screening
inferred← citeshttps://doi.org/10.1016/j.cbi.2006.12.006openalex-snapshot
Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approach
inferred← citeshttps://doi.org/10.1016/j.cbpa.2005.05.002openalex-snapshot
Fragonomics: fragment-based drug discovery
inferred← citeshttps://doi.org/10.1016/j.cbpa.2006.06.003openalex-snapshot
How good is your screening library?
inferred← citeshttps://doi.org/10.1016/j.cbpa.2008.02.005openalex-snapshot
Fragment-based activity space: smaller is better
inferred← citeshttps://doi.org/10.1016/j.ddtec.2010.11.010openalex-snapshot
Fragment library design: efficiently hunting drugs in chemical space
inferred← citeshttps://doi.org/10.1016/j.drudis.2007.08.005openalex-snapshot
Integration of fragment screening and library design
inferred← citeshttps://doi.org/10.1016/j.drudis.2008.10.006openalex-snapshot
Two ‘Golden Ratio’ indices in fragment-based drug discovery
inferred← citeshttps://doi.org/10.1016/j.drudis.2009.03.009openalex-snapshot
Transforming fragments into candidates: small becomes big in medicinal chemistry
inferred← citeshttps://doi.org/10.1016/j.jsb.2015.05.006openalex-snapshot
High throughput screening using acoustic droplet ejection to combine protein crystals and chemical libraries on crystallization plates at high density
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2010.07.016openalex-snapshot
Structure-based drug discovery and protein targets in the CNS
inferred← citeshttps://doi.org/10.1016/s0079-6468(05)44401-xopenalex-snapshot
1 Finding Protein Kinase Hits using Structural Information
inferred← citeshttps://doi.org/10.1016/s1359-6446(05)03511-7openalex-snapshot
Fragment-based lead discovery: leads by design
inferred← citeshttps://doi.org/10.1017/cbo9780511730412.006openalex-snapshot
NMR in fragment-based drug discovery
inferred← citeshttps://doi.org/10.1021/ac400715topenalex-snapshot
Fragment Screening by Weak Affinity Chromatography: Comparison with Established Techniques for Screening against HSP90
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c01215openalex-snapshot
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c00024openalex-snapshot
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b00197openalex-snapshot
Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia
inferred← citeshttps://doi.org/10.1021/acscentsci.4c00120openalex-snapshot
Investigating and Quantifying Molecular Complexity Using Assembly Theory and Spectroscopy
inferred← citeshttps://doi.org/10.1021/acschemneuro.3c00767openalex-snapshot
Identification of a Novel Subtype-Selective α1B-Adrenoceptor Antagonist
inferred← citeshttps://doi.org/10.1021/acsomega.5c11028openalex-snapshot
Targeting PTPN22 at Nonorthosteric Binding Sites─A Fragment Approach
inferred← citeshttps://doi.org/10.1021/acsomega.9b00611openalex-snapshot
Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1
inferred← citeshttps://doi.org/10.1021/bk-2011-1076.ch001openalex-snapshot
Overview: Fragment-Based Drug Design
inferred← citeshttps://doi.org/10.1021/ci050352vopenalex-snapshot
Assessing the Scaffold Diversity of Screening Libraries
inferred← citeshttps://doi.org/10.1021/ci400731wopenalex-snapshot
Fragment-Based Lead Discovery and Design
inferred← citeshttps://doi.org/10.1021/ci800219hopenalex-snapshot
Identification and Selection of “Privileged Fragments” Suitable for Primary Screening
inferred← citeshttps://doi.org/10.1021/ja905207topenalex-snapshot
Design and NMR-Based Screening of LEF, a Library of Chemical Fragments with Different Local Environment of Fluorine
inferred← citeshttps://doi.org/10.1021/jm048972vopenalex-snapshot
Unveiling the Full Potential of Flexible Receptor Docking Using Multiple Crystallographic Structures
inferred← citeshttps://doi.org/10.1021/jm060511hopenalex-snapshot
Fragment-Based Drug Design: How Big Is Too Big?
inferred← citeshttps://doi.org/10.1021/jm100496jopenalex-snapshot
Ligand Specificity in Fragment-Based Drug Design
inferred← citeshttps://doi.org/10.1021/jm200349bopenalex-snapshot
Selectivity of Kinase Inhibitor Fragments
inferred← citeshttps://doi.org/10.1021/jm200350gopenalex-snapshot
How Well Can Fragments Explore Accessed Chemical Space? A Case Study from Heat Shock Protein 90
inferred← citeshttps://doi.org/10.1021/jm200642wopenalex-snapshot
A Small Nonrule of 3 Compatible Fragment Library Provides High Hit Rate of Endothiapepsin Crystal Structures with Various Fragment Chemotypes
inferred← citeshttps://doi.org/10.1021/jm501402xopenalex-snapshot
Promiscuous 2-Aminothiazoles (PrATs): A Frequent Hitting Scaffold
inferred← citeshttps://doi.org/10.1021/jm8000373openalex-snapshot
Recent Developments in Fragment-Based Drug Discovery
inferred← citeshttps://doi.org/10.1021/jm801385dopenalex-snapshot
Binding Site Detection and Druggability Index from First Principles
inferred← citeshttps://doi.org/10.1021/jm9000659openalex-snapshot
Design and Implementation of an Ribonucleic Acid (RNA) Directed Fragment Library
inferred← citeshttps://doi.org/10.1021/jm900357yopenalex-snapshot
Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone
inferred← citeshttps://doi.org/10.1038/nchem.2660openalex-snapshot
Dynamic undocking and the quasi-bound state as tools for drug discovery
inferred← citeshttps://doi.org/10.1038/s41589-019-0310-xopenalex-snapshot
Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3
inferred← citeshttps://doi.org/10.1039/9781782620938-00126openalex-snapshot
Fragment-Based Lead Discovery Applied to Protein–Protein Interactions
inferred← citeshttps://doi.org/10.1039/9781788018982-00188openalex-snapshot
Fragment-based Ligand Discovery (FBLD)
inferred← citeshttps://doi.org/10.1039/c5ob02461gopenalex-snapshot
Design and synthesis of dihydroisoquinolones for fragment-based drug discovery (FBDD)
inferred← citeshttps://doi.org/10.1039/d0sc01232gopenalex-snapshot
Demonstration of the utility of DOS-derived fragment libraries for rapid hit derivatisation in a multidirectional fashion
inferred← citeshttps://doi.org/10.1039/d3md00439bopenalex-snapshot
A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinase
inferred← citeshttps://doi.org/10.1042/ebc20170028openalex-snapshot
Current perspectives in fragment-based lead discovery (FBLD)
inferred← citeshttps://doi.org/10.1071/ch13280openalex-snapshot
Design and Evaluation of the Performance of an NMR Screening Fragment Library
inferred← citeshttps://doi.org/10.1071/ch13325openalex-snapshot
Construction of the CSIRO Fragment Library
inferred← citeshttps://doi.org/10.1073/pnas.1904529116openalex-snapshot
Drugging an undruggable pocket on KRAS
inferred← citeshttps://doi.org/10.1080/07391102.2012.742246openalex-snapshot
Novel G-quadruplex stabilizing agents: in-silico approach and dynamics
inferred← citeshttps://doi.org/10.1093/nar/gkl065openalex-snapshot
FAF-Drugs: free ADME/tox filtering of compound collections
inferred← citeshttps://doi.org/10.1107/s090904950705666xopenalex-snapshot
Fragment approaches in structure-based drug discovery
inferred← citeshttps://doi.org/10.1107/s1399004713034603openalex-snapshot
Hitting the target: fragment screening with acousticin situco-crystallization of proteins plus fragment libraries on pin-mounted data-collection micromeshes
inferred← citeshttps://doi.org/10.11606/t.75.2015.tde-28082015-081328openalex-snapshot
Determinação do modo de interação de inibidores reversíveis da cruzaína de Trypanosoma cruzi via cristalografia de raios X
inferred← citeshttps://doi.org/10.1177/1087057110389038openalex-snapshot
Experimental Validation of a Fragment Library for Lead Discovery Using SPR Biosensor Technology
inferred← citeshttps://doi.org/10.1177/1087057114565080openalex-snapshot
Large Scale Meta-Analysis of Fragment-Based Screening Campaigns: Privileged Fragments and Complementary Technologies
inferred← citeshttps://doi.org/10.1517/17460441.1.3.225openalex-snapshot
Fragment screening by biochemical assay
inferred← citeshttps://doi.org/10.2174/138620709787581738openalex-snapshot
A Multi-Step NMR Screen for the Identification and Evaluation of Chemical Leads for Drug Discovery
inferred← citeshttps://doi.org/10.2174/1568026054637700openalex-snapshot
Library Design for Fragment Based Screening
inferred← citeshttps://doi.org/10.2174/156802607782194725openalex-snapshot
Computational Techniques in Fragment Based Drug Discovery
inferred← citeshttps://doi.org/10.2174/156802607782341073openalex-snapshot
SPR-based Fragment Screening: Advantages and Applications
inferred← citeshttps://doi.org/10.2174/156802607782341091openalex-snapshot
An Integrated Approach to Fragment-Based Lead Generation:Philosophy, Strategy and Case Studies from AstraZenecas Drug Discovery Programmes
inferred← citeshttps://doi.org/10.31390/gradschool_dissertations.2172openalex-snapshot
Study of complex RNA function modulated by small molecules: the development of RNA directed small molecule library and probing the S-adenosyl methionine discrimination between on and off conformational states of the SAM-I riboswitch
inferred← citeshttps://doi.org/10.3389/fmicb.2016.01392openalex-snapshot
Fragment-Based Whole Cell Screen Delivers Hits against M. tuberculosis and Non-tuberculous Mycobacteria
inferred← citeshttps://doi.org/10.3389/fmolb.2022.857000openalex-snapshot
Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis
inferred← citeshttps://doi.org/10.3390/molecules23020233openalex-snapshot
NMR-Fragment Based Virtual Screening: A Brief Overview
inferred← citeshttps://doi.org/10.3390/molecules25204597openalex-snapshot
NMR as a “Gold Standard” Method in Drug Design and Discovery
inferred← citeshttps://doi.org/10.3410/f.736244523.793564639openalex-snapshot
Faculty Opinions recommendation of Drugging an undruggable pocket on KRAS.
inferred← citeshttps://doi.org/10.4155/fmc.09.149openalex-snapshot
Strategies for the Design of Rna-Binding Small Molecules
inferred← citeshttps://doi.org/10.4155/fmc.10.277openalex-snapshot
Computational Medicinal Chemistry in Fragment-Based Drug Discovery: What, How and When
inferred← citeshttps://doi.org/10.4155/fmc.11.46openalex-snapshot
The Benefits of Constructing Leads from Fragment Hits
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.